Edwards Lifesciences
Clinical trials sponsored by Edwards Lifesciences, explained in plain language.
-
New catheter device aims to fix leaky heart valve without cutting chest
Disease control CompletedThis early study tested a device called the Edwards PASCAL system, which is threaded through a blood vessel to repair the tricuspid valve in the heart. The valve can leak, causing symptoms like shortness of breath and swelling. The study included 65 people with severe leakage who…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New heart valve technology put to the test in 777 patients
Disease control CompletedThis study tested whether a new way of processing tissue for Edwards heart valves is safe and works well. 777 adults who needed a new aortic or mitral valve took part. Researchers checked for valve problems like wear or calcification over about a year, and will follow patients fo…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New catheter device offers hope for leaky heart valve patients
Disease control CompletedThis study tested a new device called the Edwards PASCAL system, which repairs leaky mitral heart valves using a thin tube inserted through a blood vessel, avoiding open-heart surgery. It involved 124 adults with moderate-to-severe mitral regurgitation who were candidates for sur…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New heart valve passes safety check in 57 patients
Disease control CompletedThis study looked at the SAPIEN XT heart valve, which is placed through a thin tube (catheter) to fix a failed valve in the heart's right ventricle. Researchers wanted to confirm it is safe and works well. They enrolled 57 people with a narrowed or leaky heart valve conduit. The …
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New heart valve offers hope for High-Risk chinese patients
Disease control CompletedThis study tested a new heart valve, the SAPIEN 3, in 58 Chinese patients with severe aortic stenosis who were at high risk for traditional open-heart surgery. The valve was implanted using a thin tube through a blood vessel, avoiding the need for open surgery. The main goal was …
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 26, 2026 16:50 UTC